Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 2.
| Dosage form | NDCs |
|---|---|
| capsule, gelatin coated | 1 |
| tablet | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| synthon hispania s.l. | 2 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Levocetirizine dihydrochloride | tablet | 43579-006DRUG FOR FURTHER PROCESSING |
| - | Tamsulosin Hydrochloride | capsule, gelatin coated | 43579-011DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing levocetirizine dihydrochloride
- Granules Pharmaceuticals Inc.8 sites · 302 NDC
- Padagis Israel Pharmaceuticals Ltd2 sites · 236 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
- CHATTEM, INC.1 site · 153 NDC
- Camber Consumer Care Inc1 site · 24 NDC
- Velocity Pharma LLC0 sites · 7 NDC
Enquiry
Common questions
- Is Synthon Hispania S.L. FDA approved?
- Synthon Hispania S.L. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Synthon Hispania S.L. make?
- 2 products are listed under Synthon Hispania S.L. in the openFDA NDC Directory, most often as capsule, gelatin coated; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.